Fig. 3From: Sirolimus enhances the protection achieved by a DNA vaccine against Leishmania infantumComparison of anti-Leishmania IgG levels in group C (PBS-inoculated control group), V (DNA vaccinated group), and S + V (sirolimus-treated and DNA vaccinated group) at 5 weeks post-challenge. Antibody levels were measured by ELISA against crude total L. infantum antigen (n = 30). Cut-off value (mean + 3 SD) was set at 0.015 OD. ANOVA; * P < 0.05Back to article page